【AI加持，领跑行业】一图读懂医脉通2025年中期业绩

医脉通科技

$医脉通(02192)$

医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发，AI产品矩阵全面升级临床价值，“AI+医学”产学研深度融合。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

谈今论股
2025-08-26
谈今论股
医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发，AI产品矩阵全面升级临床价值，“AI+医学”产学研深度融合。

发表看法

1

2

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":471374315495528,"tweetId":"471374315495528","gmtCreate":1756113144483,"gmtModify":1756113153488,"author":{"id":4108538557159180,"idStr":"4108538557159180","authorId":4108538557159180,"authorIdStr":"4108538557159180","name":"医脉通科技","avatar":"https://static.tigerbbs.com/537a45edbce3572962fad60d384e81e2","vip":5,"userType":5,"introduction":"感知世界医学脉播，助力中国临床决策","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19656,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/2fdd81b16e76e6b9074dc8eff0cb02eb","width":"1080","height":"13716"}],"coverImages":[{"img":"https://static.tigerbbs.com/2fdd81b16e76e6b9074dc8eff0cb02eb","width":"1080","height":"13716"}],"title":"【AI加持，领跑行业】一图读懂医脉通2025年中期业绩","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02192\">$医脉通(02192)$</a></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2fdd81b16e76e6b9074dc8eff0cb02eb\" tg-width=\"1080\" tg-height=\"13716\"></p>\n<p><strong>医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发</strong>，<strong>AI产品矩阵全面升级临床价值</strong>，<strong>“AI+医学”产学研深度融合</strong>。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02192\">$医脉通(02192)$</a></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2fdd81b16e76e6b9074dc8eff0cb02eb\" tg-width=\"1080\" tg-height=\"13716\"></p>\n<p><strong>医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发</strong>，<strong>AI产品矩阵全面升级临床价值</strong>，<strong>“AI+医学”产学研深度融合</strong>。</p></body></html>","text":"$医脉通(02192)$ 医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发，AI产品矩阵全面升级临床价值，“AI+医学”产学研深度融合。","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/471374315495528","repostId":0,"isVote":1,"tweetType":1,"viewCount":48834,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02192"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":186,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":471683166388528,"commentId":"471683166388528","gmtCreate":1756188454975,"gmtModify":1756188458730,"authorId":4107612084981750,"author":{"id":4107612084981750,"idStr":"4107612084981750","authorId":4107612084981750,"name":"谈今论股","avatar":"https://static.tigerbbs.com/59ec5fb35863484255ebc8aebe767f64","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":471374315495528,"objectIdStr":"471374315495528","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"<p>医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发，AI产品矩阵全面升级临床价值，“AI+医学”产学研深度融合。</p>","text":"<p>医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发，AI产品矩阵全面升级临床价值，“AI+医学”产学研深度融合。</p>","html":"<p>医脉通发布了2025年中期业绩，在自研医学垂类大模型的深度赋能下，公司核心业务实现高质量增长，医生生态与AI技术双轮驱动业务爆发，AI产品矩阵全面升级临床价值，“AI+医学”产学研深度融合。</p>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/471374315495528"}